Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 2.0 |
Min SIP Amount | ₹100 | ₹1000 |
Expense Ratio | 1.42 | 1.77 |
NAV | ₹1914.11 | ₹36.48 |
Fund Started | 08 Dec 1994 | 11 Feb 2015 |
Fund Size | ₹66304.16 Cr | ₹6354.33 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year
| Exit load of 0.5%, if redeemed within 90 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 30.41% | 22.49% |
3 Year | 24.42% | 10.23% |
5 Year | 24.16% | 22.05% |
1 Year
3 Year
5 Year
Equity | 87.35% | 98.59% |
Cash | 11.88% | -0.37% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.75% |
ICICI Bank Ltd. | 9.71% |
Axis Bank Ltd. | 8.23% |
Cipla Ltd. | 4.44% |
Kotak Mahindra Bank Ltd. | 4.39% |
Maruti Suzuki India Ltd. | 4.18% |
SBI Life Insurance Company Ltd. | 4.07% |
Bharti Airtel Ltd. | 4.01% |
HCL Technologies Ltd. | 3.90% |
Piramal Pharma Ltd. | 2.94% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.61% |
ICICI Bank Ltd. | 7.42% |
Tata Consultancy Services Ltd. | 3.99% |
Reliance Industries Ltd. | 3.81% |
Varun Beverages Ltd. | 3.32% |
Persistent Systems Ltd. | 2.98% |
Bharti Airtel Ltd. | 2.67% |
Dixon Technologies (India) Ltd. | 2.59% |
Multi Commodity Exchange Of India Ltd. | 2.45% |
Sun Pharmaceutical Industries Ltd. | 2.29% |
Name | Dhruv Muchhal | Vivek Sharma |
Start Date | 14 Sep 2023 | 15 Apr 2024 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. | The scheme seeks to generate income & capital appreciation by predominantly investing in an actively managed diversified portfolio of equity & equity related instruments including derivatives. |
Launch Date | 08 Dec 1994 | 11 Feb 2015 |
Description
Launch Date